We spoke with Cambridge’s most recent Nobel Laureate about decades of research, spin-outs, pharma giants and the booming life sciences cluster in Greater Cambridge.
The path from innovation to impact can be long and complex. Here we describe the 30-year journey behind the development of a drug now being used to treat multiple sclerosis.